ACD Pharma
Norway - LeknesPharmaceutical
Focus: ACD Pharma is a Norway-based biotech founded in 2019 focused on bacteriophage therapeutics targeting neurology indications. The company operates as a pre-revenue stage biotech with a small team structure.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
1-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at ACD Pharma?
AI assessmentACD Pharma presents a high-risk, early-stage opportunity best suited to risk-tolerant scientists seeking ground-floor exposure to bacteriophage science rather than near-term career advancement.
Why Work Here
- Early-stage exposure to emerging bacteriophage modality in a nascent therapeutic area with limited competitive saturation
- Opportunity to shape scientific direction and company culture at a newly founded organization (founded 2019)
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for ACD Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.